{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T04:38:00Z","timestamp":1719031080915},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.1248\/bpb.b23-00067","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T22:58:44Z","timestamp":1693522724000},"page":"1211-1216","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of Diagnosis Timing of Attention-Deficit\/Hyperactivity Disorder in Working-Age Workers with Psychiatric Diseases Using Large Claims Data"],"prefix":"10.1248","volume":"46","author":[{"given":"Mutsumi","family":"Ando","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy Division of Clinical Research and Development, School of Pharmacy, Showa University"},{"name":"Department of Hospital Pharmaceutics, School of Pharmacy, Showa University"},{"name":"Department of Pharmacy, Showa University Karasuyama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Momo","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmaceutics, School of Pharmacy, Showa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Hida","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy Division of Clinical Research and Development, School of Pharmacy, Showa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taigi","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy Division of Clinical Research and Development, School of Pharmacy, Showa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iori","family":"Taki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy Division of Clinical Research and Development, School of Pharmacy, Showa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmaceutics, School of Pharmacy, Showa University"},{"name":"Department of Pharmacy, Showa University Karasuyama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yoshio","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmaceutics, School of Pharmacy, Showa University"},{"name":"Department of Pharmacy, Showa University Karasuyama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kurosawa","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmaceutics, School of Pharmacy, Showa University"},{"name":"Department of Pharmacy, Showa University Karasuyama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Spencer TJ, Biederman J, Mick E. Attention-deficit\/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. <i>Ambul. Pediatr.<\/i>, <b>7<\/b> (Suppl.), 73\u201381 (2007).","DOI":"10.1016\/j.ambp.2006.07.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M, Harrington H, Hogan S, Meier MH, Polanczyk GV, Poulton R, Ramrakha S, Sugden K, Williams B, Rohde LA, Caspi A. Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. <i>Am. J. Psychiatry<\/i>, <b>172<\/b>, 967\u2013977 (2015).","DOI":"10.1176\/appi.ajp.2015.14101266"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Willcutt EG. The prevalence of DSM-IV attention-deficit\/hyperactivity disorder: a meta-analytic review. <i>Neurotherapeutics<\/i>, <b>9<\/b>, 490\u2013499 (2012).","DOI":"10.1007\/s13311-012-0135-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: an update. <i>Pharmacotherapy<\/i>, <b>29<\/b>, 656\u2013679 (2009).","DOI":"10.1592\/phco.29.6.656"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. <i>Am. J. Psychiatry<\/i>, <b>163<\/b>, 716\u2013723 (2006).","DOI":"10.1176\/ajp.2006.163.4.716"},{"key":"6","unstructured":"6) Uchiyama S, Ohnishi M, Nakamura K, Takebayashi K, Ninomiya T, Suzuki K, Tsujii M, Mori N. Nihon ni okeru Seijinki ADHD no Ekigakuchousa: adult ADHD self report scale-screener (ASRS-screener) Youseigun no Tokuchou ni tsuite. <i>Kodomo no Kokoro to Nou no Hattatsu = The Journal of child &amp; brain development<\/i>, <b>3<\/b>, 23\u201333 (2012)."},{"key":"7","unstructured":"7) Uchiyama S, Ohnishi M, Nakamura K, Takebayashi K, Ninomiya T, Suzuki K, Tsujii M, Mori N. Nihon ni okeru Seijinki ADHD no Ekigakuchousa: Seijinki ADHD no Yuubyouritsu ni tsuite. <i>Kodomo no Kokoro to Nou no Hattatsu = The Journal of child &amp; brain development<\/i>, <b>3<\/b>, 34\u201342 (2012)."},{"key":"8","unstructured":"8) ADHD no Shindan Chiryou Shishin ni Kansuru Kenkyu-Kai [Study Group on Diagnostic and Treatment Guidelines for ADHD]. <i>Chuuiketsujo Tadoushou\u2014ADHD\u2014no Shindan Chiryou guidelines<\/i> <i>[Attention Deficit\/Hyperactivity Disorder\u2014ADHD\u2014Diagnosis and Treatment Guidelines] <\/i>(Saito K ed.) 4th ed., Jiho, Inc., Tokyo (2016)."},{"key":"9","unstructured":"9) <i>Seijinki ADHD Shinryou guidebook [Adult ADHD treatment guidebook]<\/i>. (Higuchi T, Saito K eds.) Jiho, Inc., Tokyo (2013)."},{"key":"10","unstructured":"10) NHK. \u201cOtona no Chuuiketsujo\u30fbTadoushou (ADHD) toha? Tokuchou ya Chiryou wo Kaisetsu! [What is Adult Attention Deficit\/Hyperactivity Disorder (ADHD)? Explain the characteristics and treatment!]\u201d: \u2039https:\/\/www.nhk.or.jp\/kenko\/atc_1070.html\u203a, accessed 22 May, 2023."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kolar D, Keller A, Golfinopoulos M, Cumyn L, Syer C, Hechtman L. Treatment of adults with attention-deficit\/hyperactivity disorder. <i>Neuropsychiatr. Dis. Treat.<\/i>, <b>4<\/b>, 389\u2013403 (2008).","DOI":"10.2147\/NDT.S6985"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ford-Jones PC. Misdiagnosis of attention deficit hyperactivity disorder: \u2018Normal behaviour\u2019 and relative maturity. <i>Paediatr. Child Health<\/i>, <b>20<\/b>, 200\u2013202 (2015).","DOI":"10.1093\/pch\/20.4.200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Long N, Coats H. The need for earlier recognition of attention deficit hyperactivity disorder in primary care: a qualitative meta-synthesis of the experience of receiving a diagnosis of ADHD in adulthood. <i>Fam. Pract.<\/i>, <b>39<\/b>, 1144\u20131155 (2022).","DOI":"10.1093\/fampra\/cmac038"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Able SL, Johnston JA, Adler LA, Swindle RW. Functional and psychosocial impairment in adults with undiagnosed ADHD. <i>Psychol. Med.<\/i>, <b>37<\/b>, 97\u2013107 (2007).","DOI":"10.1017\/S0033291706008713"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) McGough JJ, Smalley SL, McCracken JT, Yang M, Del\u2019Homme M, Lynn DE, Loo S. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. <i>Am. J. Psychiatry<\/i>, <b>162<\/b>, 1621\u20131627 (2005).","DOI":"10.1176\/appi.ajp.162.9.1621"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Torgersen T, Gjervan B, Rasmussen K. ADHD in adults: a study of clinical characteristics, impairment and comorbidity. <i>Nord. J. Psychiatry<\/i>, <b>60<\/b>, 38\u201343 (2006).","DOI":"10.1080\/08039480500520665"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sobanski E, Br\u00fcggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit\/hyperactivity disorder (ADHD). <i>Eur. Arch. Psychiatry Clin. Neurosci.<\/i>, <b>257<\/b>, 371\u2013377 (2007).","DOI":"10.1007\/s00406-007-0712-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit\/hyperactivity disorder. <i>Biol. Psychiatry<\/i>, <b>57<\/b>, 456\u2013463 (2005).","DOI":"10.1016\/j.biopsych.2004.11.043"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P, Johnston JA, Spencer T, \u00dcst\u00fcn TB. The prevalence and effects of adult attention deficit\/hyperactivity disorder on work performance in a nationally representative sample of workers. <i>J. Occup. Environ. Med.<\/i>, <b>47<\/b>, 565\u2013572 (2005).","DOI":"10.1097\/01.jom.0000166863.33541.39"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Daviss WB, Birmaher B, Diler RS, Mintz J. Does pharmacotherapy for attention-deficit\/hyperactivity disorder predict risk of later major depression? <i>J. Child Adolesc. Psychopharmacol.<\/i>, <b>18<\/b>, 257\u2013264 (2008).","DOI":"10.1089\/cap.2007.0100"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T. Data resource profile: JMDC claims database sourced from health insurance societies. <i>J. Gen. Fam. Med.<\/i>, <b>22<\/b>, 118\u2013127 (2021).","DOI":"10.1002\/jgf2.422"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T. Data resource profile: JMDC claims databases sourced from Medical Institutions. <i>J. Gen. Fam. Med.<\/i>, <b>21<\/b>, 211\u2013218 (2020).","DOI":"10.1002\/jgf2.367"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Clemow DB, Bushe C, Mancini M, Ossipov MH, Upadhyaya H. A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities. <i>Neuropsychiatr. Dis. Treat.<\/i>, <b>13<\/b>, 357\u2013371 (2017).","DOI":"10.2147\/NDT.S115707"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) James A, Lai FH, Dahl C. Attention deficit hyperactivity disorder and suicide: a review of possible associations. <i>Acta Psychiatr. Scand.<\/i>, <b>110<\/b>, 408\u2013415 (2004).","DOI":"10.1111\/j.1600-0447.2004.00384.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit\/hyperactivity disorder reduces risk for substance use disorder. <i>Pediatrics<\/i>, <b>104<\/b>, e20 (1999).","DOI":"10.1542\/peds.104.2.e20"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. <i>Pediatrics<\/i>, <b>124<\/b>, 71\u201378 (2009).","DOI":"10.1542\/peds.2008-3347"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff HB, Elliott G, Hechtman L, Hoza B, March JS, Newcorn JH, Severe JB, Vitiello B, Wells K, Wigal T. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. <i>J. Dev. Behav. Pediatr.<\/i>, <b>22<\/b>, 60\u201373 (2001).","DOI":"10.1097\/00004703-200102000-00008"},{"key":"28","unstructured":"28) Biederman J. Pharmacotherapy for attention-deficit\/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. <i>J. Clin. Psychiatry<\/i>, <b>64<\/b> (Suppl. 11), 3\u20138 (2003)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/9\/46_b23-00067\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:51:47Z","timestamp":1715575907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/9\/46_b23-00067\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b23-00067","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"article-number":"b23-00067"}}